Skip to main content
. 2023 Jul 20;24(14):11710. doi: 10.3390/ijms241411710

Table 3.

Evaluation of circulating cytokines, cytokine profiles, and cytokine ratios between individual groups (i.e., ASD, ADHD, and control groups) with respect to sex.

Parameter Controls a
(n = 20)
Control Females b (n = 5) Control Males c (n = 15) ASD d
(n = 20)
ASD Females e
(n = 5)
ASD Males f (n = 15) ADHD g
(n = 20)
ADHD Females h (n = 5) ADHD Males i
(n = 15)
Cytokines
IL-1α
(pg/mL)
0.21 (0.18, 0.22) 0.21 (0.19, 0.22) 0.21 (0.18, 0.22) 0.25 (0.21, 0.30) 0.70 (0.57, 0.74) 0.24 (0.21, 0.28) 0.13 (0.11, 0.21) 0.21 (0.08, 0.37) 0.13 (0.11, 0.17)
IL-1β
(pg/mL)
0.88 (0.68, 0.97) 0.64 (0.62, 0.91) 0.88 (0.75, 1.05) 1.19 (0.93, 1.69) 1.08 (0.93, 2.06) 1.21 (0.97, 1.61) 1.28 (1.02, 2.83) 1.13 (1.11, 1.31) 1.80 (0.94, 2.97)
IL-2
(pg/mL)
1.68 (1.26, 2.21) 1.40 (1.01, 1.74) 1.88 (1.33, 2.38) 2.25 (1.70, 4.97) 5.12 (2.55, 7.66) 2.19 (1.70, 3.92) 1.19 (0.92, 1.68) 1.78 (1.28, 1.88) 1.07 (0.86, 1.28)
IL-4
(pg/mL)
1.89 ± 0.37 1.92 ± 0.13 1.88 ± 0.11 2.37 ± 0.72 2.61 ± 0.41 2.31 ± 0.18 1.69 ± 0.40 1.66 ± 0.15 1.70 ± 0.12
IL-6
(pg/mL)
0.52 (0.37, 0.63) 0.53 (0.38, 0.68) 0.52 (0.37, 0.61) 0.81 (0.66, 1.43) 1.35 (1.00, 1.85) 0.74 (0.65, 1.00) 1.17 (1.06, 1.45) 1.15 (1.10, 1.69) 1.21 (0.98, 1.43)
IL-8
(pg/mL)
3.38 (3.06, 3.88) 3.29 (3.19, 3.48) 3.70 (2.98, 4.36) 4.48 (3.90, 5.42) 5.85 (5.36, 6.29) 4.27 (3.83, 5.06) 3.05 (2.54, 3.44) 2.96 (2.67, 3.31) 3.08 (2.49, 3.46)
IL-10
(pg/mL)
0.61 (0.51, 0.70) 0.66 (0.52, 0.72) 0.58 (0.51, 0.67) 0.96 (0.70, 1.76) 1.77 (0.79, 1.99) 0.80 (0.68, 1.32) 0.54 (0.50, 0.82) 0.52 (0.50, 0.62) 0.55 (0.50, 0.85)
IFN-γ
(pg/mL)
0.29 (0.19, 0.42) 0.31 (0.16, 0.37) 0.28 (0.19, 0.46) 0.28 (0.22, 0.36) 0.37 (0.34, 0.44) 0.26 (0.16, 0.30) 0.43 (0.28, 0.55) 0.29 (0.18, 0.54) 0.44 (0.26, 0.53)
TNF-α
(pg/mL)
2.22 ± 0.84 1.74 ± 0.14 2.38 ± 0.23 2.57 ± 0.81 3.04 ± 0.51 2.42 ± 0.17 3.73 ± 0.98 4.06 ± 0.47 3.62 ± 0.25
Cytokine profiles
Th1 profile −0.53 ± 1.22 −0.95 ± 0.46 −0.40 ± 0.33 0.10 ± 1.51 1.14 ± 1.20 −0.16 ± 0.38 −0.09 ± 1.30 0.55 ± 0.69 −0.33 ± 0.33
M1 profile −1.88 (−2.68, −0.72) −2.51 (−3.57, −1.70) −1.76 (−2.67, −0.47) −0.31 (−1.48, 0.58) −1.47 (−1.47, 1.38) −0.25 (−1.53, 0.52) 1.85 (1.13, 3.27) 2.20 (1.74, 3.23) 1.83 (0.39, 3.25)
proinflammatory profile −2.44 ± 3.31 −4.15 ± 0.99 −1.83 ± 0.93 −0.14 ± 2.53 1.93 ± 1.70 −0.52 ± 0.74 1.01 ± 2.60 1.70 ± 1.39 0.84 ± 0.79
anti-inflammatory profile −0.35 (−1.55, 0.18) −0.30 (−0.36, −0.04) −0.74 (−1.81, 0.20) 0.84 (−0.32, 2.93) 1.93 (0.28, 3.63) 0.84 (−0.38, 2.52) −0.91 (−1.78, −0.34) −0.97 (−1.05, −0.72) −0.85 (−1.92, −0.19)
Cytokine ratios
Th1/Th2
ratio
−0.23 ± 1.24 −0.93 ± 0.33 0.01 ± 0.34 −0.43 ± 0.95 0.03 ± 0.76 −0.51 ± 0.28 0.46 ± 1.27 1.11 ± 0.82 0.21 ± 0.27
Th1/Treg ratio −0.03 ± 1.00 −0.55 ± 0.56 0.15 ± 0.23 −0.36 ± 1.08 0.32 ± 0.58 −0.52 ± 0.31 0.33 ± 1.44 1.09 ± 0.72 0.01 ± 0.38
Th1/Th2+
Treg ratio
0.28 ± 1.21 −0.54 ± 0.52 0.55 ± 0.29 −0.75 ± 0.98 0.01 ± 0.63 −0.87 ± 0.28 0.95 ± 1.33 1.65 ± 0.81 0.66 ± 0.30
Proinflammatory/
anti-inflammatory ratio
−1.78 ± 2.82 −3.74 ± 1.02 −1.07 ± 0.73 −0.59 ± 1.82 1.85 ± 1.30 −1.03 ± 0.45 1.66 ± 2.52 2.49 ± 1.38 1.43 ± 0.79

ASD—autism spectrum disorder; ADHD—attention deficit/hyperactivity disorder; IL — interleukin; IFN-γ—interferon-gamma; TNF-α—tumor necrosis factor-alpha; Th—T helper lymphocytes; M1—macrophages M1; Treg—T regulatory lymphocytes. Data are expressed as mean ± SEM or median (interquartile range). a indicates the control group; b indicates the control females; c indicates the control males; d indicates the whole ASD group; e indicates the ASD females; f indicates the ASD males; g indicates the whole ADHD group; h indicates the ADHD females; i indicates the ADHD males.